Ken Griffin Twist Bioscience Corp Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$36.72 - $58.88 $238,680 - $382,720	-6,500 Reduced 57.52%	4,800 $216,000
Q2 2024 Aug 14, 2024	SELL	$27.95 - $53.0 $198,445 - $376,300	-7,100 Reduced 38.59%	11,300 $556,000
Q1 2024 May 15, 2024	SELL	$32.28 - $41.5 $2.19 Million - $2.81 Million	-67,700 Reduced 78.63%	18,400 $631,000
Q4 2023 Feb 14, 2024	BUY	$15.08 - $38.61 $666,536 - $1.71 Million	44,200 Added 105.49%	86,100 $3.17 Million
Q3 2023 Nov 14, 2023	SELL	$18.62 - $26.57 $687,078 - $980,433	-36,900 Reduced 46.83%	41,900 $848,000
Q2 2023 Aug 14, 2023	BUY	$11.49 - $20.46 $522,795 - $930,930	45,500 Added 136.64%	78,800 $1.61 Million
Q1 2023 May 15, 2023	BUY	$14.6 - $30.9 $303,680 - $642,720	20,800 Added 166.4%	33,300 $502,000
Q4 2022 Feb 14, 2023	BUY	$21.92 - $39.37 $133,712 - $240,156	6,100 Added 95.31%	12,500 $297,000
Q3 2022 Nov 14, 2022	SELL	$33.44 - $56.56 $244,111 - $412,888	-7,300 Reduced 53.28%	6,400 $226,000

258

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.7B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.